Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presentation ACC 2026

Protect The Head To Head Trial: A Randomized Comparison Of Emboliner Embolic Protection System vs. Sentinel Cerebral Protection System During Transcatheter Aortic Valve Replacement

Presenter: Adam Greenbaum

March 29, 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

March 28, 2026

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

Presentation ACC 2026

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

Presenter: Saibal Kar

March 28, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF

News Conference News ACC 2023

PULSED AF ‘Strengthens the Case’ for Pulsed-Field Ablation in AF

March 06, 2023

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

Presentation ACC 2023

Pulsed Field Ablation Treatment in Paroxysmal and Persistent Atrial Fibrillation Patients: Acute and Long-term Outcomes from the PULSED AF Pivotal Trial

Presenter: Atul Verma

March 05, 2023

Managing AF Patients Undergoing PCI—Some Lingering Questions

News Conference News ACC 2022

Managing AF Patients Undergoing PCI—Some Lingering Questions

Michael O'Riordan

April 12, 2022

Large Smartwatch Study Confirms AF in Most Patients Who Seek Care: mAF-App II

News Conference News ACC 2022

Large Smartwatch Study Confirms AF in Most Patients Who Seek Care: mAF-App II

Yael L. Maxwell

April 07, 2022

Leaks After LAA Occlusion Tied to Uptick in Thromboembolic Events

News Conference News ACC 2022

Leaks After LAA Occlusion Tied to Uptick in Thromboembolic Events

April 04, 2022

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

News Conference News ACC 2021

RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients

May 17, 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

News Conference News ACC 2021

Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC

Michael O'Riordan

May 17, 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

News Conference News ACC 2021

Low 1-Year Stroke Risk After Commercial Watchman Use

May 15, 2021

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

News Conference News ACC 2021

Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III

May 15, 2021

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

News Conference News ACC 2020

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

April 06, 2020

Aspirin Okay for Up to 30 Days

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

April 03, 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

News Conference News ACC 2020

A-fib Patients Undergoing TAVR Do Better With OAC Alone: POPular TAVI

March 29, 2020

Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds

News Conference News ACC 2020

Low Mortality Rates Seen With Andexanet Alfa for Factor Xa-Related Bleeds

March 25, 2020

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presentation ACC 2019

Apixaban vs VKA and Aspirin vs Placebo in Patients with Atrial Fibrillation and ACS/PCI: The AUGUSTUS Trial

Presenter: Renato Lopes

March 18, 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

News Conference News ACC 2019

AUGUSTUS: Apixaban Plus P2Y12 Inhibitor the Best Combo in A-fib Patients With ACS or Undergoing PCI

March 17, 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

News Conference News ACC 2019

Apple Watch May Detect A-fib in the General Population, but at What Cost?

Yael L. Maxwell

March 16, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.